AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 NOV 14 - (NewsRx.com & NewsRx.net) -- Hologic, Inc., (HOLX), a provider of women's diagnostic imaging systems and digital radiography systems, announced it received final approval from the U.S. Food and Drug Administration (FDA) for a premarket approval (PMA) supplement which covers the use of the company's proprietary DirectRay amorphous-selenium, direct-to-digital image receptor for its LORAD Selenia Full Field Digital Mammography (FFDM) System.
The Selenia generates digital mammographic images that can be used for screening and diagnosis of breast cancer and is intended for use in the same clinical applications as traditional screen-film mammography systems. Mammographic images can be interpreted on either hard copy film or the ...